PASW
Income statement / Annual
Last year (2025), Ping An Biomedical Co Ltd.'s total revenue was $34.15 M,
a decrease of 61.03% from the previous year.
In 2025, Ping An Biomedical Co Ltd.'s net income was -$12.83 M.
See Ping An Biomedical Co Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
09/30/2025 |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
| Operating Revenue |
$34.15 M |
$87.62 M |
$82.56 M |
$114.55 M |
$99.52 M |
| Cost of Revenue |
$33.20 M
|
$82.21 M
|
$78.32 M
|
$100.40 M
|
$85.25 M
|
| Gross Profit |
$949.51 K
|
$5.42 M
|
$4.24 M
|
$14.14 M
|
$14.27 M
|
| Gross Profit Ratio |
0.03
|
0.06
|
0.05
|
0.12
|
0.14
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$6.00 M
|
$4.54 M
|
$2.88 M
|
$2.76 M
|
$2.93 M
|
| Selling & Marketing Expenses |
$299.96 K
|
$306.58 K
|
$332.51 K
|
$350.21 K
|
$436.77 K
|
| Selling, General & Administrative Expenses |
$6.30 M
|
$4.85 M
|
$3.21 M
|
$3.11 M
|
$3.37 M
|
| Other Expenses |
$9.35 M
|
$570.64 K
|
$416.75 K
|
$222.40 K
|
$2.63 M
|
| Operating Expenses |
$15.65 M
|
$5.42 M
|
$3.63 M
|
$3.33 M
|
$6.00 M
|
| Cost And Expenses |
$48.85 M
|
$87.62 M
|
$81.95 M
|
$103.73 M
|
$91.25 M
|
| Interest Income |
$326.35 K
|
$2.03 K
|
$156.14 K
|
$42.34 K
|
$4.42 K
|
| Interest Expense |
$307.06 K
|
$705.27 K
|
$1.74 M
|
$1.57 M
|
$1.36 M
|
| Depreciation & Amortization |
$5.59 K
|
$450.78 K
|
$416.75 K
|
$414.44 K
|
$391.49 K
|
| EBITDA |
-$14.37 M |
$473.34 K |
$2.20 M |
$11.61 M |
$9.57 M |
| EBITDA Ratio |
-0.42
|
0.01
|
0.03
|
0.1
|
0.1
|
| Operating Income Ratio |
-0.43
|
-0
|
0.01
|
0.09
|
0.08
|
| Total Other Income/Expenses Net |
$16.68 K
|
-$680.68 K
|
-$570.80 K
|
-$1.19 M
|
-$447.64 K
|
| Income Before Tax |
-$14.68 M
|
-$682.72 K
|
$41.69 K
|
$9.63 M
|
$7.82 M
|
| Income Before Tax Ratio |
-0.43
|
-0.01
|
0
|
0.08
|
0.08
|
| Income Tax Expense |
-$1.86 M
|
$601.46 K
|
$1.04 M
|
$2.40 M
|
$2.61 M
|
| Net Income |
-$12.83 M
|
-$1.28 M
|
-$993.94 K
|
$7.23 M
|
$5.21 M
|
| Net Income Ratio |
-0.38
|
-0.01
|
-0.01
|
0.06
|
0.05
|
| EPS |
0 |
0 |
-0.0485 |
0.35 |
0.38 |
| EPS Diluted |
0 |
0 |
-0.0485 |
0.35 |
0.38 |
| Weighted Average Shares Out |
$0.00
|
$0.00
|
$20.50 M
|
$20.50 M
|
$13.75 M
|
| Weighted Average Shares Out Diluted |
$0.00
|
$0.00
|
$20.50 M
|
$20.50 M
|
$13.75 M
|
| Link |
|
|
|
|
|
